Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.
The Alopecia drugs in development market research report provides an overview of the Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects.
What are the targets of the Alopecia pipeline drugs market?
Some of the targets of the Alopecia pipeline drugs market are Tyrosine Protein Kinase JAK1, 3-Oxo 5-Alpha Steroid 4 Dehydrogenase 2, Tyrosine Protein Kinase JAK2, Tyrosine Protein Kinase JAK3, Androgen Receptor, ATP Sensitive Inward Rectifier Potassium Channel 8 (Inward Rectifier K, ATP Sensitive Inward Rectifier Potassium Channel 11, CXXC Type Zinc Finger Protein 5, Prostaglandin F2 Alpha, and Sphingosine 1-Phosphate Receptor 1.
Alopecia pipeline drugs market, by targets
For more target insights, download a free report sample
What are the mechanisms of action of the Alopecia pipeline drugs market?
Some of the mechanisms of action of the Alopecia pipeline drugs market are Tyrosine Protein Kinase JAK1 Inhibitor, Oxo 5 Alpha Steroid 4 Dehydrogenase 2 Inhibitor, Tyrosine Protein Kinase JAK2 Inhibitor, Tyrosine Protein Kinase JAK3 Inhibitor, ATP Sensitive Inward Rectifier Potassium Channel 8 (Inward Rectifier KActivator, Androgen Receptor Antagonist, ATP Sensitive Inward Rectifier Potassium Channel 11 Activator, CXXC Type Zinc Finger Protein 5 Inhibitor, Sphingosine 1-Phosphate Receptor 1 Agonist, and Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase Activator.
Alopecia pipeline drugs market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
What are the routes of administration in the Alopecia pipeline drugs market?
The routes of administration in the Alopecia pipeline drugs market are topical, oral, subcutaneous, intravenous, parenteral, ophthalmic, cutaneous, injection, intradermal, and transdermal.
Alopecia pipeline drugs market, by routes of administration
For more routes of administration insights, download a free report sample
What are the molecule types in the Alopecia pipeline drugs market?
The molecule types in the Alopecia pipeline drugs market are small molecule, cell therapy, monoclonal antibody, oligonucleotide, recombinant protein, antisense RNAi oligonucleotide, peptide, protein, synthetic peptide, and aptamer.
Alopecia pipeline drugs market, by molecule types
For more molecule type insights, download a free report sample
Which are the key companies in the Alopecia pipeline drugs market?
Some of the key companies in the Alopecia pipeline drugs market are Applied Biology Inc, Jiangsu Hengrui Medicine Co Ltd, Kintor Pharmaceutical Ltd, Pfizer Inc, Addpharma Inc, Almirall SA, CK Regeon Inc, HCell Inc, Kuhnil Pharmaceutical Co Ltd, and ProTransit Nanotherapy LLC.
Alopecia pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report scope
| Targets | Tyrosine Protein Kinase JAK1, 3-Oxo 5-Alpha Steroid 4 Dehydrogenase 2, Tyrosine Protein Kinase JAK2, Tyrosine Protein Kinase JAK3, Androgen Receptor, ATP Sensitive Inward Rectifier Potassium Channel 8 (Inward Rectifier K, ATP Sensitive Inward Rectifier Potassium Channel 11, CXXC Type Zinc Finger Protein 5, Prostaglandin F2 Alpha, and Sphingosine 1-Phosphate Receptor 1. |
| Mechanisms of Action | Tyrosine Protein Kinase JAK1 Inhibitor, Oxo 5 Alpha Steroid 4 Dehydrogenase 2 Inhibitor, Tyrosine Protein Kinase JAK2 Inhibitor, Tyrosine Protein Kinase JAK3 Inhibitor, ATP Sensitive Inward Rectifier Potassium Channel 8 (Inward Rectifier KActivator, Androgen Receptor Antagonist, ATP Sensitive Inward Rectifier Potassium Channel 11 Activator, CXXC Type Zinc Finger Protein 5 Inhibitor, Sphingosine 1-Phosphate Receptor 1 Agonist, and Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase Activator |
| Routes of Administration | Topical, Oral, Subcutaneous, Intravenous, Parenteral, Ophthalmic, Cutaneous, Injection, Intradermal, and Transdermal |
| Molecule Types | Small Molecule, Cell Therapy, Monoclonal Antibody, Oligonucleotide, Recombinant Protein, Antisense Rnai Oligonucleotide, Peptide, Protein, Synthetic Peptide, and Aptamer |
| Key Companies | Applied Biology Inc, Jiangsu Hengrui Medicine Co Ltd, Kintor Pharmaceutical Ltd, Pfizer Inc, Addpharma Inc, Almirall SA, CK Regeon Inc, HCell Inc, Kuhnil Pharmaceutical Co Ltd, and ProTransit Nanotherapy LLC |
This report provides:
- A snapshot of the global therapeutic landscape of Alopecia (Dermatology).
- Reviews of pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- Key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
- Evaluation of Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news related to pipeline therapeutics for Alopecia (Dermatology).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.
Aclaris Therapeutics Inc
Addpharma Inc
Akaal Pharma Pty Ltd
Alexion Pharmaceuticals Inc
Almirall SA
AnaptysBio Inc
Aneira Pharma Inc
AnTolRx Inc
Applied Biology Inc
Berg LLC
Biolab Sanus Farmaceutica Ltda
BiologicsMD Inc
Bioquark Inc
BirchBioMed Inc
Caregen Co Ltd
Chong Kun Dang Pharmaceutical Corp
CK Regeon Inc
Concert Pharmaceuticals Inc
Cosmo Pharmaceuticals NV
Dermaliq Therapeutics Inc
dNovo Inc
Eli Lilly and Co
Energenesis Biomedical Co Ltd
Equillium Inc
Exicure Inc
Follica Inc
Haplnscience Inc
HCell Inc
HCW Biologics Inc
Hope Medicine Inc
Horizon Therapeutics Plc
Inventage Lab Inc
Japan Tobacco Inc
Jiangsu Hengrui Medicine Co Ltd
JN Biosciences LLC
Johnson & Johnson
JW Pharmaceutical Corp
Kedi Biomedical Co Ltd
Kintor Pharmaceutical Ltd
Kuhnil Pharmaceutical Co Ltd
LG Chem Ltd
Maxinovel Pharmaceuticals
METiS Pharmaceuticals
Mirae Cell Bio Co Ltd
Nepsone ehf
OliX Pharmaceuticals Inc
Omega Therapeutics Inc
OnQuality Pharmaceuticals LLC
Pfizer Inc
Phio Pharmaceuticals Corp
Ponce Therapeutics Inc
ProTransit Nanotherapy LLC
RiverTown Therapeutics Inc
Samson Clinical Pty Ltd
Shenzhen Chipscreen Biosciences Co Ltd
siRNAgen Therapeutics Corp
Sisaf Ltd
Soterios Ltd
Stemson Therapeutics Corp
Suzhou Zelgen Biopharmaceutical Co Ltd
TagCyx Biotechnologies
Technoderma Medicines Inc
Throne Biotechnologies Inc
Tigo GmbH
Triple Hair Inc
Tritech Biopharmaceuticals Co Ltd
Turn Biotechnologies Inc
VasoDynamics Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Alopecia pipeline drugs market?
Some of the targets of the Alopecia pipeline drugs market are Tyrosine Protein Kinase JAK1, 3-Oxo 5-Alpha Steroid 4 Dehydrogenase 2, Tyrosine Protein Kinase JAK2, Tyrosine Protein Kinase JAK3, Androgen Receptor, ATP Sensitive Inward Rectifier Potassium Channel 8 (Inward Rectifier K, ATP Sensitive Inward Rectifier Potassium Channel 11, CXXC Type Zinc Finger Protein 5, Prostaglandin F2 Alpha, and Sphingosine 1-Phosphate Receptor 1.
-
What are the mechanisms of action of the Alopecia pipeline drugs market?
Some of the mechanisms of action of the Alopecia pipeline drugs market are Tyrosine Protein Kinase JAK1 Inhibitor, Oxo 5 Alpha Steroid 4 Dehydrogenase 2 Inhibitor, Tyrosine Protein Kinase JAK2 Inhibitor, Tyrosine Protein Kinase JAK3 Inhibitor, ATP Sensitive Inward Rectifier Potassium Channel 8 (Inward Rectifier KActivator, Androgen Receptor Antagonist, ATP Sensitive Inward Rectifier Potassium Channel 11 Activator, CXXC Type Zinc Finger Protein 5 Inhibitor, Sphingosine 1-Phosphate Receptor 1 Agonist, and Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase Activator.
-
What are the routes of administration in the Alopecia pipeline drugs market?
The routes of administration in the Alopecia pipeline drugs market are topical, oral, subcutaneous, intravenous, parenteral, ophthalmic, cutaneous, injection, intradermal, and transdermal.
-
What are the molecule types in the Alopecia pipeline drugs market?
The molecule types in the Alopecia pipeline drugs market are small molecule, cell therapy, monoclonal antibody, oligonucleotide, recombinant protein, antisense RNAi oligonucleotide, peptide, protein, synthetic peptide, and aptamer.
-
Which are the key companies in the Alopecia pipeline drugs market?
Some of the key companies in the Alopecia pipeline drugs market are Applied Biology Inc, Jiangsu Hengrui Medicine Co Ltd, Kintor Pharmaceutical Ltd, Pfizer Inc, Addpharma Inc, Almirall SA, CK Regeon Inc, HCell Inc, Kuhnil Pharmaceutical Co Ltd, and ProTransit Nanotherapy LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Dermatology reports